FDA Will Approve COVID-19 Vaccine
Digest more
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
Wellbeing Whisper on MSN18h
Navigating the New COVID-19 Vaccine Rules Who Can Get the Updated Shots This FallThe truth is that for most of that, for many Americans, we simply do not know the answer to whether or not they should be getting the seven or eight or nine or ten, as the current policy would have us,
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for approving future Covid-19 vaccines that he feels will counteract existing “dogma.”
12h
Scripps News on MSNFDA committee meets to discuss COVID vaccine target for fall amid access restrictionsThe FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots for those under 65.
Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal of Medicine, authored by Prasad and FDA Commissioner
1don MSN
Long before he joined the FDA to run the center that regulates vaccines, Vinay Prasad argued against COVID shots for kids. Among his many criticisms of the United States’ approach to combatting the disease,